Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shanghai Rongtai Health Technology's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:603579'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.25 Med: 1.45 Max: 5.06
Current: 1.77
During the past 13 years, Shanghai Rongtai Health Technology's highest Yield on Cost was 5.06. The lowest was 0.25. And the median was 1.45.
SHSE:603579's 5-Year Yield-on-Cost % is ranked worse than 69.44% of 409
companies
in the Travel & Leisure industry
Industry Median: 3.04
vs SHSE:603579: 1.77
Shanghai Rongtai Health Technology (SHSE:603579) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Shanghai Rongtai Health Technology 5-Year Yield-on-Cost % Related Terms
SHSE:603579 vs AS, HAS, LTH: 5-Year Yield-on-Cost % Comparison
For the Leisure subindustry, Shanghai Rongtai Health Technology's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Rongtai Health Technology 5-Year Yield-on-Cost % vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Shanghai Rongtai Health Technology's 5-Year Yield-on-Cost % falls into.
Shanghai Rongtai Health Technology 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Shanghai Rongtai Health Technology (SHSE:603579) has a 5-Year Yield-on-Cost % of 1.77 as of Sep. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shanghai Rongtai Health Technology and its competitors. This is 22% above median its historical median of 1.45. Over the past decade, Shanghai Rongtai Health Technology's 5-Year Yield-on-Cost % has ranged from 0.25 to 5.06. According to the industry distribution chart, Shanghai Rongtai Health Technology ranks #284 out of 409 companies in the Travel & Leisure industry, placing it in the top 69.4%.
Is Shanghai Rongtai Health Technology's 5-Year Yield-on-Cost % too high?
Shanghai Rongtai Health Technology's current 5-Year Yield-on-Cost % of 1.77 is 22% above median its 10-year median of 1.45. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 5.06. The Travel & Leisure industry median 5-Year Yield-on-Cost % is 3.04. Shanghai Rongtai Health Technology's value of 1.77 is 41.8% below this industry median. Based on the distribution chart, Shanghai Rongtai Health Technology ranks #284 out of 409 companies in the Travel & Leisure industry, which is below the industry midpoint. Overall, Shanghai Rongtai Health Technology has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rongtai Health Technology's 5-Year Yield-on-Cost % compare to AS and HAS?
According to the Travel & Leisure industry distribution chart, Shanghai Rongtai Health Technology ranks #284 out of 409 companies for 5-Year Yield-on-Cost %. This places Shanghai Rongtai Health Technology in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.04. Shanghai Rongtai Health Technology's value of 1.77 is 41.8% below this benchmark. Historically, Shanghai Rongtai Health Technology's own 5-Year Yield-on-Cost % has ranged from 0.25 to 5.06 over the past decade. While the company's 10-year median is 1.45 vs. the industry median of 3.04, Shanghai Rongtai Health Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Travel & Leisure company?
The median 5-Year Yield-on-Cost % among Travel & Leisure companies is 3.04, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Rongtai Health Technology's current 5-Year Yield-on-Cost % of 1.77 is 41.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shanghai Rongtai Health Technology and its competitors. For the Travel & Leisure industry, the median 5-Year Yield-on-Cost % is 3.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Rongtai Health Technology's current 5-Year Yield-on-Cost % is 1.77, which is 22% above median its own 10-year median of 1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rongtai Health Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology (SHSE:603579) is currently considered Fairly Valued. The stock's GF Value™ is ¥17.52, compared to a current price of ¥18.19 — trading 3.8% above its estimated fair value. The current 5-Year Yield-on-Cost % is 1.77, which is 22% above median its 10-year median of 1.45 and 41.8% below the Travel & Leisure industry median of 3.04. Shanghai Rongtai Health Technology's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Shanghai Rongtai Health Technology (SHSE:603579), the current 5-Year Yield-on-Cost % is 1.77 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Rongtai Health Technology (SHSE:603579) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology stock appears to be overvalued.
The current stock price of ¥18.19 is trading 3.8% above its estimated GF Value™ of ¥17.52.
GuruFocus considers Shanghai Rongtai Health Technology to be Fairly Valued.
Key valuation signals for SHSE:603579:
5-Year Yield-on-Cost %: 1.77 (22% above median its 10-year median of 1.45)
GF Value™: ¥17.52 vs. price of ¥18.19 (3.8% above fair value)
Industry Position: 41.8% below the Travel & Leisure median (#284 of 409)
No single metric tells the full story. See the SHSE:603579 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
68GF Score
Get the complete analysis for SHSE:603579
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603579 has been successfully added to your 
